167 related articles for article (PubMed ID: 30932437)
1. Novel autoantibodies in rheumatoid arthritis.
Bonifacio AF; Alunno A; La Paglia GMC; Valentini E; Leone MC; Bartoloni E; Gerli R
Reumatismo; 2019 Apr; 71(1):1-12. PubMed ID: 30932437
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.
Pratesi F; Tommasi C; Anzilotti C; Puxeddu I; Sardano E; Di Colo G; Migliorini P
Clin Exp Immunol; 2011 Jun; 164(3):337-45. PubMed ID: 21413944
[TBL] [Abstract][Full Text] [Related]
4. Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis.
Carubbi F; Alunno A; Gerli R; Giacomelli R
Cells; 2019 Jun; 8(7):. PubMed ID: 31261953
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.
Vossenaar ER; Després N; Lapointe E; van der Heijden A; Lora M; Senshu T; van Venrooij WJ; Ménard HA
Arthritis Res Ther; 2004; 6(2):R142-50. PubMed ID: 15059278
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
Konig MF; Giles JT; Nigrovic PA; Andrade F
Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
de Brito Rocha S; Baldo DC; Andrade LEC
Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
[TBL] [Abstract][Full Text] [Related]
9. Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis.
Ospelt C; Bang H; Feist E; Camici G; Keller S; Detert J; Krämer A; Gay S; Ghannam K; Burmester GR
Ann Rheum Dis; 2017 Jul; 76(7):1176-1183. PubMed ID: 28183721
[TBL] [Abstract][Full Text] [Related]
10. The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients.
Jearn LH; Kim TY
Arthritis Res Ther; 2010; 12(5):406; author reply 407. PubMed ID: 21067558
[No Abstract] [Full Text] [Related]
11. Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies.
Sorice M; Iannuccelli C; Manganelli V; Capozzi A; Alessandri C; Lococo E; Garofalo T; Di Franco M; Bombardieri M; Nerviani A; Misasi R; Valesini G
Rheumatology (Oxford); 2016 Aug; 55(8):1374-85. PubMed ID: 27074807
[TBL] [Abstract][Full Text] [Related]
12. Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
Figueiredo CP; Bang H; Cobra JF; Englbrecht M; Hueber AJ; Haschka J; Manger B; Kleyer A; Reiser M; Finzel S; Tony HP; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz HM; Nuesslein H; Alten R; Henes J; Krueger K; Rech J; Schett G
Ann Rheum Dis; 2017 Feb; 76(2):399-407. PubMed ID: 27323772
[TBL] [Abstract][Full Text] [Related]
13. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
14. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
15. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
Harre U; Georgess D; Bang H; Bozec A; Axmann R; Ossipova E; Jakobsson PJ; Baum W; Nimmerjahn F; Szarka E; Sarmay G; Krumbholz G; Neumann E; Toes R; Scherer HU; Catrina AI; Klareskog L; Jurdic P; Schett G
J Clin Invest; 2012 May; 122(5):1791-802. PubMed ID: 22505457
[TBL] [Abstract][Full Text] [Related]
16. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
17. Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.
Trejo-Zambrano MI; Gómez-Bañuelos E; Andrade F
Antioxid Redox Signal; 2022 Mar; 36(7-9):389-409. PubMed ID: 33906423
[No Abstract] [Full Text] [Related]
18. Clinical significance of anti-CCP antibodies in rheumatoid arthritis.
Mimori T
Intern Med; 2005 Nov; 44(11):1122-6. PubMed ID: 16357447
[TBL] [Abstract][Full Text] [Related]
19. Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.
Baka Z; Barta P; Losonczy G; Krenács T; Pápay J; Szarka E; Sármay G; Babos F; Magyar A; Géher P; Buzás EI; Nagy G
Int Immunol; 2011 Jun; 23(6):405-14. PubMed ID: 21602177
[TBL] [Abstract][Full Text] [Related]
20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
